Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy

Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy

Introduction: Lung adenocarcinoma (LUAD) with intestinal differentiation (LAID) comprises a rare and heterogeneous NSCLC of invasive mucinous, enteric, and colloid characteristics. In the era of chemotherapy, LAID was associated with a poorer prognosis compared with other LUADs. Leveraging the Natio...

Full description

Saved in:
Bibliographic Details
Main Authors: Micah Tratt, BA, Anshu Bandhlish, MD, Keith D. Eaton, MD, PhD, Ted Gooley, PhD, Nicholas Giustini, MD, Lei Deng, MD
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:JTO Clinical and Research Reports
Subjects:
Lung adenocarcinoma
Intestinal differentiation
Immunotherapy
Invasive mucinous adenocarcinoma
Colloid adenocarcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364325000438
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666364325000438

Similar Items